
Paul V. Ward
Examiner (ID: 13921, Phone: (571)272-2909 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624, 1623, 1622 |
| Total Applications | 2552 |
| Issued Applications | 1846 |
| Pending Applications | 195 |
| Abandoned Applications | 548 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20650355
[patent_doc_number] => 20260102366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-04-16
[patent_title] => TREATMENT FOR INTERSTITIAL LUNG DISEASE
[patent_app_type] => utility
[patent_app_number] => 19/420084
[patent_app_country] => US
[patent_app_date] => 2025-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19420084
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/420084 | TREATMENT FOR INTERSTITIAL LUNG DISEASE | Dec 14, 2025 | Pending |
Array
(
[id] => 20598925
[patent_doc_number] => 20260076928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-03-19
[patent_title] => TREATMENT FOR INTERSTITIAL LUNG DISEASE
[patent_app_type] => utility
[patent_app_number] => 19/400211
[patent_app_country] => US
[patent_app_date] => 2025-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19400211
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/400211 | TREATMENT FOR INTERSTITIAL LUNG DISEASE | Nov 24, 2025 | Pending |
Array
(
[id] => 20598926
[patent_doc_number] => 20260076929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-03-19
[patent_title] => TREATMENT FOR INTERSTITIAL LUNG DISEASE
[patent_app_type] => utility
[patent_app_number] => 19/400227
[patent_app_country] => US
[patent_app_date] => 2025-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16297
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19400227
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/400227 | TREATMENT FOR INTERSTITIAL LUNG DISEASE | Nov 24, 2025 | Pending |
Array
(
[id] => 20459337
[patent_doc_number] => 20260008760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-08
[patent_title] => DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/325182
[patent_app_country] => US
[patent_app_date] => 2025-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19325182
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/325182 | DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF | Sep 9, 2025 | Pending |
Array
(
[id] => 20735502
[patent_doc_number] => 20260144792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-05-28
[patent_title] => INHIBITORS OF CHYMASE FOR USE IN THE SELECTIVE RESOLUTION OF THROMBI IN THROMBOTIC OR THROMBOEMBOLIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 19/225710
[patent_app_country] => US
[patent_app_date] => 2025-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19225710
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/225710 | INHIBITORS OF CHYMASE FOR USE IN THE SELECTIVE RESOLUTION OF THROMBI IN THROMBOTIC OR THROMBOEMBOLIC DISORDERS | Jun 1, 2025 | Pending |
Array
(
[id] => 19769927
[patent_doc_number] => 20250051353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => COMPOSITIONS OF THIENOPYRIMIDINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 18/927346
[patent_app_country] => US
[patent_app_date] => 2024-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10321
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18927346
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/927346 | Compositions of thienopyrimidine derivatives | Oct 24, 2024 | Issued |
Array
(
[id] => 19656877
[patent_doc_number] => 20240423942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-26
[patent_title] => PHARMACEUTICAL COMPOSITION INCLUDING RETINOIC ACID AND CARBOHYDRATE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/825882
[patent_app_country] => US
[patent_app_date] => 2024-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18825882
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/825882 | PHARMACEUTICAL COMPOSITION INCLUDING RETINOIC ACID AND CARBOHYDRATE AND USE THEREOF | Sep 4, 2024 | Pending |
Array
(
[id] => 19754351
[patent_doc_number] => 20250042916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => COMPOUNDS, COMPOSITIONS, AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/795041
[patent_app_country] => US
[patent_app_date] => 2024-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56392
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18795041
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/795041 | COMPOUNDS, COMPOSITIONS, AND METHODS | Aug 4, 2024 | Pending |
Array
(
[id] => 19707789
[patent_doc_number] => 20250017931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => METHODS OF PERSONALIZING CANCER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/771171
[patent_app_country] => US
[patent_app_date] => 2024-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24253
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18771171
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/771171 | METHODS OF PERSONALIZING CANCER TREATMENT | Jul 11, 2024 | Pending |
Array
(
[id] => 20443959
[patent_doc_number] => 20260000673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-01
[patent_title] => BRAIN HEALTH SUPPLEMENT
[patent_app_type] => utility
[patent_app_number] => 18/760014
[patent_app_country] => US
[patent_app_date] => 2024-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18760014
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/760014 | BRAIN HEALTH SUPPLEMENT | Jun 30, 2024 | Pending |
Array
(
[id] => 19707742
[patent_doc_number] => 20250017884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/742375
[patent_app_country] => US
[patent_app_date] => 2024-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18742375
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/742375 | Compositions and methods for treating Alzheimer's disease | Jun 12, 2024 | Issued |
Array
(
[id] => 20438615
[patent_doc_number] => 12509442
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-30
[patent_title] => KIF18A inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/680558
[patent_app_country] => US
[patent_app_date] => 2024-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33082
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 715
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18680558
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/680558 | KIF18A inhibitors | May 30, 2024 | Issued |
Array
(
[id] => 19595214
[patent_doc_number] => 12153051
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-26
[patent_title] => Reagents for quantitative mass spectrometry
[patent_app_type] => utility
[patent_app_number] => 18/626881
[patent_app_country] => US
[patent_app_date] => 2024-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 19
[patent_no_of_words] => 25144
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18626881
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/626881 | Reagents for quantitative mass spectrometry | Apr 3, 2024 | Issued |
Array
(
[id] => 19447412
[patent_doc_number] => 20240307542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => Pharmaceutical Compositions Having Improved Storage Stability
[patent_app_type] => utility
[patent_app_number] => 18/618311
[patent_app_country] => US
[patent_app_date] => 2024-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18618311
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/618311 | Pharmaceutical compositions having improved storage stability | Mar 26, 2024 | Issued |
Array
(
[id] => 19830810
[patent_doc_number] => 20250082596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-13
[patent_title] => Methods and Compositions for Treatment of Inflammatory Disease
[patent_app_type] => utility
[patent_app_number] => 18/612000
[patent_app_country] => US
[patent_app_date] => 2024-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18612000
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/612000 | Methods and compositions for treatment of inflammatory disease | Mar 20, 2024 | Issued |
Array
(
[id] => 19389376
[patent_doc_number] => 20240279246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => INJECTABLE GOLD-BASED PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/606994
[patent_app_country] => US
[patent_app_date] => 2024-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23625
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18606994
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/606994 | Injectable gold-based pharmaceutical composition | Mar 14, 2024 | Issued |
Array
(
[id] => 19473864
[patent_doc_number] => 12103940
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => Cytotoxicity assay composition and gold (III) complex
[patent_app_type] => utility
[patent_app_number] => 18/606917
[patent_app_country] => US
[patent_app_date] => 2024-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 73
[patent_no_of_words] => 23673
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18606917
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/606917 | Cytotoxicity assay composition and gold (III) complex | Mar 14, 2024 | Issued |
Array
(
[id] => 19448891
[patent_doc_number] => 20240309021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => PHARMACEUTICAL COMPOSITION WITH PRIMARY AND SECONDARY THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/606165
[patent_app_country] => US
[patent_app_date] => 2024-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23592
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18606165
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/606165 | Pharmaceutical composition with primary and secondary therapeutic agents | Mar 14, 2024 | Issued |
Array
(
[id] => 19389373
[patent_doc_number] => 20240279243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => LIQUID PHARMACEUTICAL COMPOSITION OF GOLD
[patent_app_type] => utility
[patent_app_number] => 18/606361
[patent_app_country] => US
[patent_app_date] => 2024-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18606361
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/606361 | Liquid pharmaceutical composition of gold | Mar 14, 2024 | Issued |
Array
(
[id] => 19389372
[patent_doc_number] => 20240279242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => SOLID PHARMACEUTICAL GOLD-BASED COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/606260
[patent_app_country] => US
[patent_app_date] => 2024-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18606260
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/606260 | Solid pharmaceutical gold-based composition | Mar 14, 2024 | Issued |